Cancer research meets tick vectors for infectious diseases
The Lancet. Infectious diseases.
2014 Oct ;
14 (10) :
916-7.
Language English Country United States Media print
Document type Journal Article
Persistent link
https://www.medvik.cz/link/pmid25253398
PubMed
25253398
DOI
10.1016/s1473-3099(14)70902-8
PII: S1473-3099(14)70902-8
Knihovny.cz E-resources
- MeSH
- Arachnid Vectors immunology MeSH
- Cetuximab MeSH
- Antibodies, Monoclonal, Humanized adverse effects therapeutic use MeSH
- Immunoglobulin E blood MeSH
- Tick Infestations immunology MeSH
- Ticks immunology MeSH
- Humans MeSH
- Neoplasms drug therapy immunology MeSH
- Tick-Borne Diseases immunology MeSH
- Antineoplastic Agents adverse effects therapeutic use MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- United States MeSH
- Names of Substances
- Cetuximab MeSH
- Antibodies, Monoclonal, Humanized MeSH
- Immunoglobulin E MeSH
- Antineoplastic Agents MeSH
Erratum In
Lancet Infect Dis. 2014 Oct;14(10):917 PubMed
References provided by Crossref.org
Environmental and Molecular Drivers of the α-Gal Syndrome
Oncotarget.
2017 Mar 28 ;
8 (13) :
20630-20644.
